Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-12-001571
Filing Date
2012-08-10
Accepted
2012-08-10 17:23:15
Documents
8
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 URIGEN PHARMACEUTICALS, INC. FORM 10-K form10k.htm 10-K 3480556
2 EXHIBIT 10.27 ex1027.htm EX-10.27 54627
3 EXHIBIT 10.31 ex1031.htm EX-10.31 60940
4 EXHIBIT 10.35 ex1035.htm EX-10.35 15943
5 EXHIBIT 21.1 ex211.htm EX-21.1 5362
6 EXHIBIT 23.1 ex231.htm EX-23.1 3579
7 EXHIBIT 31.1 ex311.htm EX-31.1 17148
8 EXHIBIT 32.1 ex321.htm EX-32.1 7725
  Complete submission text file 0001013762-12-001571.txt   3647057
Mailing Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809 (925) 280-2861
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-22987 | Film No.: 121025367
SIC: 2834 Pharmaceutical Preparations